CORRELATION BETWEEN SYNDECAN-1 PROTEIN EXPRESSION AND MALIGNANT PHENOTYPES OF HEPATOCELLULAR CARCINOMA_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

Department of Hepato-Bili-Pancreato Surgery, The First Affiliated Hospital, Nanjing University of Medical Sciences, Nanjing 210029;

Corresponding author：

Keywords：

Hepatocellular carcinoma Proteoglycan

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the relationship between syndecan-1 protein and malignant phenotypes of hepatocellular carcinoma (HCC).
Methods forty-seven formalin-fixed sections were obtained. The syndecan-1 was measured with immunohistochemistry assay (ABC method).
Results Among 47 HCC tissues, 28 (59.6%) show negative staining, the syndecan-1 negative rate in HCC with poor differentiation was higher than those with good differentiation (78.3% vs 41.7%, Ｐ＜0.05), and negative rate in large HCC was higher than in small HCC (81.0% vs 42.3%, Ｐ＜0.01), and negative rate in HCC with the presence of tumor-cells in blood was greater than in those without tumor-cells in blood (84.2% vs 42.9%, P＜0.01). No correlation was found between syndecan-1 expression and serum AFP level and Child class. Conclusion Syndecan-1 expression is correlated with the growth, differentiation, invasiveness, metastasis and progression of HCC. It is possible that syndecan-1 is a negative regulator of these malignant phenotypes of HCC, can be regarded as suppressive gene.

Citation： WANG Xuehao,CHENG Feng,QIAN Jianmin,et al.. CORRELATION BETWEEN SYNDECAN-1 PROTEIN EXPRESSION AND MALIGNANT PHENOTYPES OF HEPATOCELLULAR CARCINOMA. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2001, 8(4): 239-241. doi: Copy

1.	Inki P, Joensuu H, Grenman R, et al. Association between syndecan1 expression and clinical outcome in squamous cell carcinoma of the head and neck 〔Ｊ〕. Br J Cancer, 1994; 70(2)∶319.
2.	Bernfield M, Kokenyesi P, Kato M, et al. Biology of the syndecans 〔Ｊ〕. Ann Rev Biochem, 1992; 8∶365.
3.	Roskams T, Moshage H, De Vos R, et al. Heparan sulfate proteoglycan expression in normal human liver 〔Ｊ〕. Hepatology, 1995; 21(4)∶950.
4.	Roskams T, De Vos R, David G, et al. Heparan sulphate proteoglycan expression in human primary liver tumors 〔Ｊ〕. J Pathol, 1998; 185(3)∶290.
5.	Matsumoto A, Ono M, Fujimoto Y, et al. Reduced expression of syndecan1 in human hepatocellular carcinoma with high metastatic potential 〔Ｊ〕. Int J Cancer, 1997; 74(5)∶482.
6.	Mali M, Andfolk H, Miettinen HM, et al. Suppression of tumor cell growth by syndecan1 ectodomain 〔Ｊ〕. J Biol Chem, 1994; 269(45)∶27795.
7.	KumarSingh S, Jacobs W, Dhaene K, et al. Syndecan1 expression in maligant mesothlioma: correlation with differentiation, wtl expression, and clinical outcome 〔Ｊ〕. J Pathol, 1998; 186(3)∶300.
8.	Izumi R, Shimizu K, Li T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection 〔Ｊ〕. Gastroenterology, 1994; 106(3)∶720.

1. Inki P, Joensuu H, Grenman R, et al. Association between syndecan1 expression and clinical outcome in squamous cell carcinoma of the head and neck 〔Ｊ〕. Br J Cancer, 1994; 70(2)∶319.
2. Bernfield M, Kokenyesi P, Kato M, et al. Biology of the syndecans 〔Ｊ〕. Ann Rev Biochem, 1992; 8∶365.
3. Roskams T, Moshage H, De Vos R, et al. Heparan sulfate proteoglycan expression in normal human liver 〔Ｊ〕. Hepatology, 1995; 21(4)∶950.
4. Roskams T, De Vos R, David G, et al. Heparan sulphate proteoglycan expression in human primary liver tumors 〔Ｊ〕. J Pathol, 1998; 185(3)∶290.
5. Matsumoto A, Ono M, Fujimoto Y, et al. Reduced expression of syndecan1 in human hepatocellular carcinoma with high metastatic potential 〔Ｊ〕. Int J Cancer, 1997; 74(5)∶482.
6. Mali M, Andfolk H, Miettinen HM, et al. Suppression of tumor cell growth by syndecan1 ectodomain 〔Ｊ〕. J Biol Chem, 1994; 269(45)∶27795.
7. KumarSingh S, Jacobs W, Dhaene K, et al. Syndecan1 expression in maligant mesothlioma: correlation with differentiation, wtl expression, and clinical outcome 〔Ｊ〕. J Pathol, 1998; 186(3)∶300.
8. Izumi R, Shimizu K, Li T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection 〔Ｊ〕. Gastroenterology, 1994; 106(3)∶720.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

CORRELATION BETWEEN SYNDECAN-1 PROTEIN EXPRESSION AND MALIGNANT PHENOTYPES OF HEPATOCELLULAR CARCINOMA

Abstract Full text Figures/Tables Video References Cited by

Format

Content